肿瘤负荷在上皮性卵巢癌中的研究进展  

Research Progress on Tumor Load in Epithelial Ovarian Cancer

作　　者：周睿 倪静[1] 赵倩[1] 董珈吟 程贤中 肖莉 徐霞[1] 陈小祥[1] ZHOU Rui;NI Jing;ZHAO Qian;DONG Jia-yin;CHENG Xian-zhong;XIAO Li;XU Xia;CHEN Xiao-xiang(The Affiliated Cancer Hospital of Nanjing Medical University,Jiangsu Cancer Hospital,Jiangsu Institute of Cancer Research,Nanjing 210009,China)

机构地区：[1]南京医科大学附属肿瘤医院江苏省肿瘤医院江苏省肿瘤防治研究所,江苏南京210009

出　　处：《肿瘤学杂志》2022年第10期866-871,共6页Journal of Chinese Oncology

基　　金：国家自然科学基金(81472441);江苏省妇幼健康科研项目(F202004);北京市康华中西医发展基金-乐基金(KH-2020-LJJ-021,KH-2021-LLZX-058)。

摘　　要：肿瘤负荷泛指肿瘤细胞的数量、肿瘤大小或体内病灶的数量,其评估形式多样,在预测药物疗效及疾病预后方面有重要意义。在上皮性卵巢癌的发生、发展过程中,监测肿瘤负荷对评估其疗效及预后有重要意义。关于肿瘤负荷的评估在上皮性卵巢癌患者治疗选择方面已有大量研究,同时也为上皮性卵巢癌患者的预后预测带来了希望。全文就肿瘤负荷应用于预测上皮性卵巢癌疗效及预后的研究进展进行综述。Tumor load, which refers to the number of tumor cells, the size of the tumor or the number of lesions in the body, is assessed using various methods and is important for predicting drug efficacy and disease prognosis. The assessment of the tumor load in epithelial ovarian cancer has been extensively studied which is applied for therapeutic modality selection and prognosis prediction of patients with epithelial ovarian cancer. The article reviews the research progress on the application of tumor load in predicting the treatment efficacy and prognosis of patients with epithelial ovarian cancer.

关 键 词：肿瘤负荷 上皮性卵巢癌 临床标志物 

分 类 号：R737.31[医药卫生—肿瘤]